Schmidt, S., Liu, Y., Hu, Z., Williams, K. M., Lazarus, H. M., Vij, R., . . . Saber, W. (2020). The Role of Donor Lymphocyte Infusion (DLI) in Post Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era. Biol Blood Marrow Transplant.
Citação norma ChicagoSchmidt, Sarah, et al. "The Role of Donor Lymphocyte Infusion (DLI) in Post Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era." Biol Blood Marrow Transplant 2020.
Citação norma MLASchmidt, Sarah, et al. "The Role of Donor Lymphocyte Infusion (DLI) in Post Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era." Biol Blood Marrow Transplant 2020.